Claude fails to create scorpion antivenom drug
Original title: Claude did not invent scorpion antivenom
Anthropic Claude generated protein binders for scorpion venom toxins but did not produce functional antivenom.
Citrini Research collaborated with Anthropic to test Claude on designing scorpion antivenom. The model produced nearly 320000 candidates which were reduced to 211 designs after lab testing. Seventeen proteins bound to four of five target toxins but experts state translation to actual medicines remains a major challenge.
- Claude generated 320000 candidates over 64 hours.
- Seventeen proteins bound four of five scorpion toxins.
- No proteins bound more than one toxin.
- Binding does not equal functional antivenom.
- Experiment cost nearly 200000 dollars.
- Vendors
- Anthropic
- Products
- Claude
- Organizations
- Citrini Research
From the original article
5 min read at theverge.com
An investment research firm wanted to prove AI could revolutionize drug development. So they teamed up with Anthropic to see whether an unreleased version of Claude could make scorpion antivenom. It couldn't.
By Robert Hart · theverge.com
A short excerpt; the article and its images belong to the publisher. Summary, key facts and assessment above are AI-written from the article and can be wrong.